Deborah L. Weitzman
Chief Executive Officer, Pharmaceutical And Specialty Solutions Segment
Cardinal Health Inc · CAH
$5.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed September 16, 2025. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $742K
- Stock Awards
- $3.8M
- Incentives
- $965K
- Other
- $30K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $741,932 | $3,771,217 | $5,507,857 |
| 2024 | $709,153 | $3,598,977 | $5,088,847 |
| 2023 | $606,139 | $2,672,523 | $4,071,661 |
Current Position
- Company
- Cardinal Health Inc
- Title
- Chief Executive Officer, Pharmaceutical And Specialty Solutions Segment
- Ticker
- CAH · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed September 16, 2025), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0000721371-25-000114.
Other Cardinal Health Executives
Jason M. Hollar
Chief Executive Officer
Cardinal Health · CAH
$19M
FY 2025 · DEF 14A
Aaron E. Alt
Chief Financial Officer
Cardinal Health · CAH
$6.2M
FY 2025 · DEF 14A
Stephen M. Mason
Chief Executive Officer, Global Medical Products And Distribution Segment
Cardinal Health · CAH
$4.7M
FY 2025 · DEF 14A
Jessica L. Mayer
Chief Legal And Compliance Officer
Cardinal Health · CAH
$4.9M
FY 2025 · DEF 14A